Syncom Formulations (India) Limited (BSE: 524470)
Health Care · Pharmaceuticals · IN
Rs23.26
-2.96% today · +37.0% 1Y
Syncom Formulations (India) Limited (BSE: 524470) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $225.92M.
Over the last twelve months the share price has gained 37.0%, trading between 10.21 and 27.53.
Tweenvest scores Syncom Formulations (India) Limited across four factors: quality 69/100, value 47/100, growth 70/100, dividend 11/100. Its strongest factor is growth.
524470 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $225.92M
- Revenue (TTM)
- $52.65M
- P/E
- 25.86
- EPS
- 0.90
- Dividend yield
- 0.43%
- Beta (5Y)
- 0.83
- 52-week high
- Rs27.53
- 52-week low
- Rs10.21
- Avg volume (3M)
- —
- Shares outstanding
- 940.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Sol-Gel Technologies Ltd.NasdaqCM: SLGL | $234.97M | $71.77 | -0.32% |
| High Tide Inc.TSXV: HITI | $234.28M | CA$3.75 | +1.90% |
| Sakar Healthcare LimitedNSEI: SAKAR | $232.54M | Rs1,011.50 | -5.91% |
| Savior Lifetec CorporationTPEX: 4167 | $228.12M | NT$22.00 | +12.53% |
| Sai Parenteral's LimitedNSEI: SAIPARENT | $225.46M | Rs493.90 | -5.68% |
| Venus Remedies LimitedBSE: 526953 | $225.23M | Rs1,630.75 | -8.61% |
| Imexpharm CorporationHOSE: IMP | $220.14M | ₫37,000.00 | +1.09% |
| Indoco Remedies LimitedNSEI: INDOCO | $220.03M | Rs230.70 | -8.36% |
Figures last refreshed Oct 11, 2026.